UNSPSC 51294305: Cotinine fumarate

This classification denotes a cns stimulant with the molecular formula 2C10H12N2O.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6ZAF060BHS, chemically known as n-methyl-2-(3-pyridyl)-5-pyrrolidone fumarate, but more generally known as cotinine fumarate, which bears US NIH Compound Identifier 5702029. European Medicines Agency schedules cotinine fumarate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06811MIG.

Most nations, for tariff purposes, schedule cotinine fumarate under HS 29399900. Cotinine fumarate bears US NLM identifiers UMLS ID C2825238 and NCI Concept Code C80524. SMILES: CN1[C@@H](CCC1=O)C2CCCNC2.CN1[C@@H](CCC1=O)C2CCCNC2.C(=C/C(=O)O)\C(=O)O.

UNSPSC 51294305 Cotinine fumarate is a Commodity code that in practice encompasses pharmaceutical procurement by state and local health agencies, though recent opportunities tagged to this code show significant scope mismatch. Seminole County, Florida issued IFB 60459723LAS in June 2026 for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission posted an RFI in April 2026 exploring direct-to-manufacturer prescription fulfillment models; neither solicitation involves cotinine fumarate specifically. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) solicited generic multi-source pharmaceuticals and OTC products in January 2026, a broader pharmaceutical procurement that better reflects typical activity under this code tier. State and local buyers under this code include health departments, cooperative purchasing alliances, and county public health agencies. The recent opportunities indicate that state and local government procurement tagged to this code actually spans naloxone, OTC products, generic pharmaceuticals, and prescription-fulfillment infrastructure rather than niche active pharmaceutical ingredients like cotinine fumarate.

Geographic activity centers on Florida, Texas, and Minnesota based on recent solicitations, with interstate cooperative purchasing (MMCAP serves multiple states including Oregon) widening the footprint. The Seminole County IFB closed July 26, 2023 (note: posted date shows June 30, 2026, but response deadline is dated 2023, indicating a data discrepancy in the source), with annual requirements of 1,900 units of naloxone and 800 safe drug deactivation systems; the Texas HHS RFI posted April 3, 2026 is exploratory and carries no award timeline; and the MMCAP RFP for generic pharmaceuticals and OTC products closed March 26, 2026 with contract awards effective July 1, 2026. The code shows limited recent activity directly supporting cotinine fumarate procurement, and bidders evaluating this code should note that the tagged opportunities focus on broader pharmaceutical categories, public health interventions, and managed procurement through authorized wholesaler networks rather than specialty active pharmaceutical ingredients.